Literature DB >> 3065338

Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns.

J J Lee1, J A Marvin, D M Heimbach, B J Grube.   

Abstract

In previous reports, 5% sulfamylon solution has been utilized on unexcised burns and granulation tissue. We prospectively evaluated 67 burn patients to determine graft take and the incidence of side effects with use of sulfamylon solution dressings after excision and grafting. Of patients excised and grafted, the mean graft take for a total of 100 procedures was 86%. Rash occurred in 18% of patients and sulfamylon was discontinued with no sequelae. Twenty-five percent had at least one positive fungal wound culture, yet only 3% required treatment for candidemia. Those patients who developed a rash and fungal colonization had a significantly larger percent burn and were treated with sulfamylon for a longer period of time. Pain intensity was rated on a Visual Analog Scale with a mean score of 2.4; in no case was the pain considered severe enough by the patient to terminate treatment. Acidosis was present in 3% of patients but felt to be unrelated to the sulfamylon treatment. As an antimicrobial agent, 5% sulfamylon solution is a viable alternative for fresh autografts with excellent graft take and acceptable side effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065338     DOI: 10.1097/00004630-198811000-00005

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  3 in total

Review 1.  Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends.

Authors:  Erwin A Kruger; Marilyn Pires; Yvette Ngann; Michelle Sterling; Salah Rubayi
Journal:  J Spinal Cord Med       Date:  2013-05-21       Impact factor: 1.985

2.  Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study.

Authors:  M Ghadiri; W Chrzanowski; R Rohanizadeh
Journal:  J Mater Sci Mater Med       Date:  2014-07-16       Impact factor: 3.896

3.  A simple cost-saving measure: 2.5% mafenide acetate solution.

Authors:  Amir Ibrahim; Shawn Fagan; Tim Keaney; Karim A Sarhane; Derek A Hursey; Philip Chang; Rob Sheridan; Colleen Ryan; Ronald Tompkins; Jeremy Goverman
Journal:  J Burn Care Res       Date:  2014 Jul-Aug       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.